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ABSTRACT 
Alcohol dependence is a chronic relapsing disorder caused by drug x gene x 
environment interactions for which pharmacotherapy is but moderately effective. The 
prefrontal cortex is a brain region important for cognitive control / behavioral flexibility 
which function is impaired in alcoholics. Although the exact role of the dynorphin / κ-
opioid receptor system in alcohol dependence is unknown, it has been suggested to 
contribute to the psychopathology of this disorder. Consistently, prodynorphin gene 
and dynorphin peptide expression is increased in the prefrontal cortex of alcoholic men. 
The aim of this thesis was to identify molecular mechanisms underlying these 
alterations. In line with this aim, we have shown that prodynorphin is regulated by the 
transcriptional control protein repressor element 1 silencing transcription factor in vitro 
and that repressor element 1 silencing transcription factor target gene and protein 
expression is altered in the prefrontal cortex of alcoholic men. 
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5-CSRTT 5-choice serial reaction time task 
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 edition 
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GATA-1 GATA binding protein 1 (globin transcription factor 1) 
GR Glucocorticoid receptor 
HIV Human immunodeficiency virus 
HMBS Hydroxymethylbilane synthase 
JUND JUN D proto-oncogene 
MEIS-1 MEIS homeobox 1 
MIR MicroRNA 
NF-κB Nuclear factor κ-
NPTX1 
light-chain-enhancer of activated B cells 
Neuronal pentraxin 1 
OPRK1 Opioid receptor, κ 1 
PDYN Prodynorphin 
PFC Prefrontal cortex 
PMI Postmortem interval 
RE1 Repressor element 1 
REST Repressor element 1 silencing transcription factor 
RIN RNA integrity number 
RPLP0 Ribosomal protein, large, P0 
SFG Superior frontal gyrus 
SNAP-25 Synaptosomal-associated protein 25 
SNARE Soluble N-ethylmaleimide-sensitive attachment protein receptor 
SNP Single nucleotide polymorphism 
SP1 Specificity protein 1 
SYP Synaptophysin 
SYX1A Syntaxin 1A 
U6 Small nuclear RNA U6 
Ta-BF T-allele binding factor 
VAMP Vesicle-associated membrane protein 
VTA Ventral tegmental area 
YY1 Yin-yang 1 
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1 INTRODUCTION 
 
1.1 ALCOHOL DEPENDENCE  
 
Alcohol dependence is diagnosed according to DSM-IV criteria as a chronic relapsing 
disorder (1). Its lifetime prevalence is ~10 % (2), and it is thought to be caused by drug 
x gene x environment interactions with heritability estimates of > 50 % (3,4). Although 
treatment (e.g. psychosocial support) is effective in 50-60 % of patients (1), fewer than 
25 % of afflicted individuals ever receive such (2). Moreover, there is no 
pharmacotherapy which improves treatment outcome by more than 20 % (still the 
benefit to cost ratio of such is 1.9-39) (1,5). These numbers reflect stigmatization (6), 
and limited knowledge about disease etiology, respectively. Thus, more research about 
alcohol dependence is warranted to counter stigma, further our understanding of the 
etiology of this disorder and identify new pharmacological targets for its treatment. 
 
1.2 PREFRONTAL CORTEX 
 
1.2.1 Function 
 
The PFC is important for cognitive control / behavioral flexibility. This function rests 
on reinforcement learning theory such that the PFC guides behavior in accordance with 
internal goals, reward prediction errors coded by mesocortical dopamine neurons and 
memories; the neural correlate of which may be persistent activity (7,8). Consistently, 
the PFC is anatomically well positioned to integrate reward prediction errors, memories 
and motor responses (7). It follows that PFC recruitment is dependent on the need for 
cognitive control a task imposes such that in the absence of a functional PFC habitual 
responses would predominate and, where those don’t exist, behavior would be 
haphazard (7). Such impulsive and disorganized behavior is a hallmark of PFC damage.  
 
1.2.2 Role in alcohol dependence 
 
Alcohol dependence is associated with atrophy, morphological changes and altered 
glucose metabolism, gene and protein expression in the PFC (9). Moreover, alcoholics 
perform worse on tasks dependent on PFC function (e.g. reward evaluation) (10). 
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Although the role of these alterations in the etiology of alcohol dependence remains to 
be determined, it has therefore been argued that the PFC plays a central role in this 
disorder (9). A mechanistic basis for such a role was recently provided in a study 
showing that acute ethanol affects persistent activity in vivo in the rat PFC in a manner 
influenced by mesocortical dopamine neurons in vitro in organotypic culture (11).  
 
1.3 DYNORPHIN / Κ-OPIOID RECEPTOR SYSTEM 
 
1.3.1 Function 
 
The κ-opioid receptor and its endogenous ligands, the dynorphin peptides, are involved 
in a wide variety of physiological responses including hedonic processing (12). 
Consistently, the κ-opioid receptor and dynorphin peptides are expressed in many of 
the brain regions that comprise the reward system (e.g. PFC and VTA) wherein they 
have been suggested to modulate neurotransmission (13). The expression of κ-opioid 
receptors in mesocortical, but not mesolimbic, dopamine neurons in the VTA, and the 
modulation of dopamine dynamics in the PFC by local and VTA κ-opioid receptors, are 
of particular interest as they make the dynorphin / κ-opioid receptor system 
anatomically well positioned to influence PFC function (e.g. reward evaluation). 
 
1.3.2 Role in alcohol dependence 
 
The role of the dynorphin /  κ-opioid receptor system in the behavioral effects of 
ethanol appears to vary with dose and mode and length of exposure (13). This system 
may initially reduce ethanol intake by opposing the positive reinforcing effects of this 
drug, while it may increase ethanol intake after repeated, heavy consumption by 
contributing to the negative reinforcing effects of drug withdrawal. Although the role of 
the PFC in these effects is yet to be determined, the evidence presented above is 
suggestive of that it may be involved. Consistently, PDYN gene and dynorphin peptide 
expression is increased in the PFC of alcoholic men (14), and genetic variants in PDYN 
and OPRK1 have been associated with alcohol dependence (15,16). 
 
1.4 REGULATION OF PDYN AND DYNORPHIN EXPRESSION 
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1.4.1 Cis 
 
Dynorphin peptides are derived from PDYN which gene has four exons and multiple 
transcription start sites (Fig. 1) (17-19). PDYN is regulated in cis by sequence variants 
located in the promoter of this gene (20-23). Among these, rs1997794 (SNP) has been 
associated with allelic imbalance (differential expression of alleles at one or more loci) 
in PDYN gene expression in the PFC (22,24). Interestingly in this regard, rs1997794 is 
located in a response element for the transcriptional control protein AP-1 (25), and 
influences its binding to this site in vitro (26). However, the causative variant may be 
one in linkage disequilibrium (nonrandom association of alleles at two or more loci) 
with rs1997794. A candidate variant is rs910080 (SNP) as: 1) it was used as a reporter 
SNP in the two studies demonstrating allelic imbalance in PDYN gene expression in the 
PFC (22,27); 2) allelic imbalance in striatal PDYN gene expression was not observed in 
the one subject analyzed who was homozygous for this locus (25); and 3) rs910080 is 
located in a RE1 bound by the transcriptional control protein REST in vivo (28). 
 
 
 
 
 
Figure 1. To scale schematic of PDYN. Shown are functional sequence variants associated with alcohol 
dependence (e.g. rs910080) and transcriptional control proteins (e.g. REST) implicated in PDYN 
regulation based on DNA-binding data or protein-protein interactions (i.e. DREAM-αCREM) 
(13,15,26,29). Transcriptional control proteins for which there are in vivo evidence of DNA-binding are 
depicted above the sequence (e.g. REST), and those for which only in vitro evidence are available below 
the sequence (e.g. AP-1). ║ = genomic regions omitted for clarity; boxes = exons; white boxes = coding 
regions; black arrow = transcription start site; grey arrows = alternative transcription start sites.  
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1.4.2 Epigenetic  
 
Methylated CpG islands (genomic regions containing a high frequency of CpG 
dinucleotides) and dinucleotides have been identified in PDYN (29,30), but the role of 
this epigenetic mark in PDYN regulation is unknown. A gene encoding a long non-
coding RNA, AK090681, is transcribed from the opposite strand of PDYN (31), and 
such RNAs are involved in epigenetic control of gene expression (32). However, PDYN 
and AK090681 may be separate but overlapping transcription units as suggested by the 
exon locations of AK090681. CTCF-mediated chromatin looping may provide a 
mechanistic basis for this separation as: 1) two transcripts lacking exons 3 and 4 have 
been reported for AK090681 (19,33); 2) these exons enclose PDYN and exon 3 and 
intron 3 of AK090681 contain response elements bound CTCF and cohesin in vivo 
(34,35); and 3) CTCF may regulate higher-order chromatin structure (36).  
 
1.4.3 Trans 
  
Transcriptional control proteins implicated in PDYN regulation are αCREM, AP-1, 
DREAM, ER, GATA-1, GR, MEIS-1, NF-κB, REST, SP1, Ta-BF and YY1 (Fig. 1) 
(13,29). (Note that transcriptional control proteins implicated in PDYN regulation based 
on in silico data alone (i.e. ER, GATA-1, MEIS-1 and SP1) have been omitted from 
Fig. 1 as this type of analysis is plagued by a high false positive rate (37)). Of these, 
αCREM, AP-1, DREAM, REST and YY1 have been shown to influence gene 
expression via their respective response elements in PDYN or protein-protein 
interactions. αCREM and AP-1 activates PDYN (13,20,23), while DREAM, REST and 
YY1 repress this gene in vitro (38-41) (paper III). However, whether αCREM, AP-1, 
DREAM or YY1 endogenously regulate PDYN remains to be determined as the gene 
expression data on these proteins are from reporter assays. Moreover, PDYN has never 
been identified as a target for any AP-1 (e.g. JUND) family member in vivo (42). 
  
1.4.4 Post-transcriptional 
 
Alternatively spliced PDYN transcripts have been identified (18,19). The role of this 
processing step in PDYN regulation is unknown, but it may contribute to dynorphin / κ-
opioid receptor system diversity (43). Consistently, the translation products of some of 
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these messages may have novel functions as suggested by their sequence similarity to 
transcriptional control proteins (44), and localization to the cell nucleus in vitro (18). 
 
1.4.5 Post-translational  
 
Although additional processing enzymes have been implicated in dynorphin peptide 
biosynthesis in vitro (45,46), this process appears to be governed primarily by the non-
selective proteases cathepsin L, prohormone convertase 1, 2 and 3 and 
carboxypeptidase E in vivo (47-49). Thus, brain regional differences in dynorphin 
peptide expression may reflect the expression patterns of these processing enzymes.  
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2 SPECIFIC AIM OF THESIS 
 
To identify molecular mechanisms underlying increased PDYN gene and dynorphin 
peptide expression in the prefrontal cortex of alcoholic men. 
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3 MATERIALS AND METHODS 
 
3.1 SUBJECTS 
 
All studies were approved by Stockholm’s ethic vetting board (permit # 04-849/4). 
Postmortem samples from 16 control and 16 alcoholic men were obtained from the 
New South Wales Tissue Resource Center; 13 per group of whom were included in all 
three studies. Cases were collected by qualified pathologists under full ethical clearance 
(protocol # X03-0117) and with informed, written consent from the next of kin. All 
subjects were Caucasian, negative for HIV and hepatitis B and C, had no brain 
abnormalities on gross examination and no history of cerebral infarction, head trauma, 
developmental or neurological disorders or illicit drug use, while the majority had a 
smoking history. Control men consumed ≤ 20 grams of ethanol / day for the majority of 
their adult lives with one exception who drank 35 grams / day, while the corresponding 
number for alcoholic men was ≥ 80 grams of ethanol / day with one exception who 
consumed 60 grams of ethanol / day. Alcoholic men met DSM-IV criteria for alcohol 
dependence and did not have Wernicke–Korsakoff´s syndrome or liver cirrhosis. 
Detailed clinical and demographic data tables are provided in papers I-III. 
 
3.2 CELL CULTURE AND TRANSFECTION 
 
Human HeLa carcinoma cells were grown in high glucose Dulbecco’s modified eagle 
medium containing 10 % fetal bovine serum at 37 oC and 5 % CO2 and transfected 
with lipofectamine™ (Invitrogen) 24 hours post plating according to the 
manufacturer’s instructions. Human neuroblastoma SH-SY5Y cells (kind gift from Dr. 
Freed WJ) were maintained in high glucose Dulbecco’s modified eagle medium 
containing 17 % fetal bovine serum at 37 oC and 5 % CO2
 
 and transfected with 
lipofectamine™ 2000 (Invitrogen) 24 hours post plating according to the 
manufacturer’s instructions. Extractions were performed 24-48 hours post transfection 
as described below.  
3.3 RNA EXTRACTION AND REAL-TIME PCR 
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3.3.1 CELLS 
 
RNA was extracted using either RNAqueous® (Ambion) (> 200 nucleotides) or 
TRIzol® (Invitrogen) (total) according to the manufacturer’s instructions and, in the 
latter case, purified using butanol / ether extraction (50). RNA was reverse transcribed 
using either iScript™ cDNA synthesis kit (Bio-Rad) (total) or TaqMan® microRNA 
reverse transcription kit (Applied Biosystems) (MIRs). If necessary, cDNA was 
preamplified using TaqMan® preamp master mix (Applied Biosystems). HotStar Taq 
DNA polymerase (Qiagen) was used for two-step real-time PCR in Applied 
Biosystems 7900HT fast real-time PCR system. Universal Probe Library assays (Roche 
Applied Science) and TaqMan® microRNA assays (Applied Biosystems) are listed in 
Table S2 in paper III. Assay cDNA specificities were verified on agarose gels. Assay 
efficacies were determined using standard curves based on RNA from untransfected 
cells. Relative gene and MIR expression was determined using the Pfaffl method (51). 
Gene expression was normalized against HMBS and MIR expression against U6.  
 
3.3.2 TISSUE 
 
RNA extraction and real-time PCR were performed as above with the exceptions that 
RNA from human PFC was used for determination of assay efficacies and that RNA 
integrity was analyzed using RNA 6000 nano kit (Agilent) in an Agilent 2100 
bioanalyzer. RIN was determined using B.02.03 (Agilent). Gene expression was 
normalized against RPLP0 and MIR expression against U6. RPLP0 was previously 
identified using geometric averaging as the most stably expressed housekeeping gene 
of those tested in the PFC of 26 out of the 32 subjects in our sample population (13 
control and 13 alcoholic men) (52), while U6 was selected as it resembles the mean 
expression value of the three MIRs analyzed (i.e. MIR-9, MIR-191 and U6) (53).  
 
3.4 CHROMATIN EXTRACTION AND IMMUNOPRECIPITATION 
 
Protein and DNA were cross-linked with 1 % formaldehyde, the reaction quenched 
with 125 millimolar glycine and chromatin extracted using 1 % SDS lysis buffer 
supplemented with phosphatase and protease inhibitors. Chromatin was shredded using 
a bioruptor (Diagenode) to ca 500 base pair fragments. Sonciated lysates were pre-
cleared using protein A agarose beads blocked with salmon sperm (Millipore) and 
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incubated with primary antibodies. Immunocomplexes were collected using blocked 
protein A agarose beads and DNA eluted in TE buffer, pH 10 supplemented with 
proteinase K. Assays were designed using RealTime PCR (Integrated DNA 
technologies) and are listed in Table S2 in paper III. iQ™ SYBR® green supermix 
(Bio-Rad) was used for one-step real-time PCR in Applied Biosystems 7900HT fast 
real-time PCR system. Assay cDNA specificities were verified on agarose gels. Assay 
efficacies were determined using standard curves based on human genomic DNA 
(Roche Applied Science). The ChIP signal was normalized against input chromatin.  
 
3.5 PROTEIN EXTRACTION AND WESTERN BLOTTING 
 
3.5.1 CELLS 
 
Protein was extracted using either RIPA buffer (Sigma-Aldrich) (total) or NE-PER® 
nuclear and cytoplasmic extraction reagents (Thermo Scientific) supplemented with 
phosphatase and protease inhibitors according to the manufacturer’s instructions. 
Protein concentration was determined using Bio-Rad protein assay. Protein was loaded 
onto 5 % tricine SDS gels, separated and transferred onto nitrocellulose membranes 
(Bio-Rad). Membranes were incubated with primary antibodies, the appropriate 
horseradish peroxidase-conjugated secondary antibody (Millipore) and ECL solution 
(GE Healthcare). Chemiluminescence was detected using a LAS-3000 charge-coupled 
device camera (Fujifilm). Densitometric analysis was performed in Multi gauge V3.0 
(Fujifilm). Protein expression was normalized against the total protein load which was 
determined using MemCode™ reversible protein stain (Thermo Scientific) (54). 
 
3.5.2 TISSUE 
 
Protein was extracted in 4 % SDS extraction buffer supplemented with phosphatase and 
protease inhibitors (total). Western blotting was performed as above with the 
exceptions that: 1) 10 % tricine SDS gels were used in papers I and II; 2) 
chemiluminescence was detected on hyperfilm ECL (GE Healthcare); 3) densitometric 
analysis was performed in Image gauge V3.12 (Fujifilm); and 4) in papers I and II, the 
linear range of detection for each protein was determined using blots made from serial 
dilutions of interblot control samples and analysis of the linear dependence of the 
protein optical densities on the corresponding MemCode optical densities.  
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3.6 STATISTICAL ANALYSIS 
 
3.6.1 CELLS 
 
Outliers were identified using Grubb’s test (www.graphpad.com). Data normality was 
assessed using Shapiro-Wilks test. Group means of gene, MIR and protein expression 
were compared between untransfected and transfected cells using one-way ANOVA 
followed by Dunnett’s post-hoc test. Statistical significance was set at p < 0.05. 
Statistical analysis was performed in Graphpad prism™ V5.0 (Graphpad Software).  
 
3.6.2 TISSUE 
 
Outliers were identified as above. Data normality was assessed using either 
Kolmogorov-Smirnov or Shapiro-Wilks test. Group means of gene, MIR and protein 
expression were compared between control and alcoholic men using backwards 
elimination to identify covariates among age, brain pH, PMI, RIN and storage time. 
Identified covariates were included in ANCOVAs. If no covariates were identified, 
group differences were evaluated using either Student’s t-test or Mann-Whitney U-test 
depending on data normality. Likewise, correlations were analyzed using either 
Pearson’s correlation or Spearman’s rank correlation. Statistical significance was set to 
P < 0.05. Statistical analysis was performed in Statistica™ V10 (StatSoft). 
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4 RESULTS 
 
4.1 PAPER I 
 
Elevated synaptophysin I in the prefrontal cortex of human chronic alcoholics 
 
PDYN is responsive to Ca2+ 55and cAMP in vitro ( ). Repeated ethanol exposure may 
alter signaling via these second messengers through effects on neurotransmitter release 
(56). Thus, in addition to the hypothesis put forth in paper I (i.e. that repeated ethanol 
exposure affects modulators of synaptic strength but not executors of neurotransmitter 
release) we hypothesized that the increased PDYN gene and dynorphin peptide 
expression observed in the PFC of alcoholic men (14) results from altered 
neurotransmitter release. To this end, we compared the expression of the presynaptic 
release machinery (i.e. SNAP-25, SYX1A and VAMP) (57), and the presynaptic 
marker, SYP (58), in the SFG, BA9 between 14 control and 14 alcoholic men. 
 
We used western blotting. SYP expression was significantly increased in the PFC of 
alcoholic men (ANCOVA, F (1, 25) = 13, P = 0.01), while the expression of SNAP-25, 
SYX1A and VAMP in this brain region did not differ significantly between control and 
alcoholic men. Consistent with the hypothesis put forth in paper I, these results indicate 
that repeated ethanol exposure affects modulators of synaptic strength but not executors 
of neurotransmitter release. However, contrary to our predictions they do not support a 
role of altered neurotransmitter release in the increased PDYN gene and dynorphin 
peptide expression observed in the PFC of alcoholic men (14), which prompted us to 
publish our findings on the presynaptic release machinery and SYP separately.  
 
4.2 PAPER II 
 
FOSB proteins in the dorsolateral and orbitofrontal cortices of human alcoholics 
 
The transcriptional control protein / AP-1 family member ΔFosB targets the mouse 
Pdyn promoter in vivo and represses it in vitro (59). The role of this protein in gene 
regulation appears to be time- and expression level-dependent with persistent, high 
expression favoring gene activation over gene repression (60). ΔFosB is accumulated in 
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the PFC of rats repeatedly exposed to ethanol (61). Thus, in addition to the hypothesis 
put forth in paper II (i.e. that drug-induced accumulation of ΔFOSB in the PFC is 
directly involved in addiction maintenance) we hypothesized that the increased PDYN 
gene and dynorphin peptide expression observed in the PFC of alcoholic men (14) 
results from accumulation of ΔFOSB. To this end, we compared the expression of 
FOSB proteins in the SFG, BA9 between 15 control and 15 alcoholic men. 
 
We used western blotting. Three FOSB proteins were detected in the adult human PFC, 
one of which was ΔFOSB. ΔFOSB expression was very low and FOSB expression in 
this brain region did not differ significantly between control and alcoholic men. 
Contrary to the hypothesis put forth in paper II, these results indicate that ΔFOSB is not 
accumulated in the PFC of alcoholic men and may not be directly involved in addiction 
maintenance. Moreover, they do not support a role of ΔFOSB in the increased PDYN 
gene and dynorphin peptide expression observed in the PFC of alcoholic men (14), 
which again prompted us to publish the findings on FOSB proteins separately. 
 
4.3 PAPER III 
 
REST regulates PDYN and REST target gene and protein expression is altered in 
the prefrontal cortex of alcoholic men 
 
PDYN is targeted by REST in vivo (28). REST is negatively regulated by the 
microRNA MIR-9 in vitro (62). Murine Rest and miR-9 are responsive to ethanol in 
vitro (63,64). Thus, we hypothesized that: 1) REST regulates PDYN; 2) the increased 
PDYN gene and dynorphin peptide expression observed in the PFC of alcoholic men 
(14) results from MIR-9- and REST-mediated derepression of REST target genes and 
proteins. To these ends, we correlated the effects of dominant negative REST and 
murine miR-9 on endogenous PDYN gene expression in human neuroblastoma SH-
SY5Y cells with REST binding to the RE1 in PDYN and compared the expression of 
MIR-9, REST protein and the REST target genes, NPTX1 and SYP, and protein, 
NPTX1, in the SFG, BA9 between 15 control and 15 alcoholic men. 
 
We used real-time PCR, ChIP and western blotting. Dominant negative REST or MIR-
9 increased endogenous PDYN gene expression in SH-SY5Y cells (ANOVA, F (3, 8) = 
38.3, P = < 0.001 and F (3, 8) = 38.3, P = < 0.05, respectively), which correlated with 
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decreased REST binding to the RE1 in PDYN (ANOVA, F (3, 8) = 10.5, P = < 0.05 
and F (3, 8) = 10.5, P = < 0.01, respectively). NPTX1 gene and protein expression was 
increased in the PFC of alcoholic men (Student’s t-test, P < 0.01 and P < 0.05, 
respectively), while SYP gene, MIR-9 and REST protein expression in this brain region 
did not differ significantly between control and alcoholic men. Consistent with the 
hypothesis put forth in paper III, these results indicate that REST is involved in 
transcriptional control of PDYN and may underlie the increased PDYN gene and 
dynorphin peptide expression observed in the PFC of alcoholic men (14). However, 
contrary to our predictions the latter effects appear not to be mediated by MIR-9. 
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5 GENERAL DISCUSSION 
 
PDYN gene and dynorphin peptide expression is increased in the PFC of alcoholic men 
(14). The specific aim of this thesis was to identify molecular mechanisms underlying 
these alterations. In line with this aim, we have shown that PDYN is regulated by REST 
in vitro and that REST target gene (i.e. NPTX1) and protein (i.e. NPTX1 and SYP) 
expression is altered in the PFC of alcoholic men. These findings implicate REST in 
the increased PDYN gene and dynorphin peptide expression observed in the PFC of 
alcoholic men (14), while our results on the SNARE proteins (i.e. SNAP-25, SYX1A 
and VAMP), FOSB proteins and MIR-9 fail to support such a role for these factors. 
 
We believe it necessary to validate mechanistic data from animal studies of disorders 
with a cognitive component such as alcohol dependence in humans as: 1) organism 
complexity may stem from progressively more elaborate patterns of gene regulation 
(65); and 2) the behavioral flexibility of humans and requirement for cognitive control 
that it imposes may be unique to our species (7). Thus: 1) while a given gene may be 
responsive to ethanol across species the underlying mechanisms may differ; and 2) the 
role of its altered expression in brain regions implicated in cognitive control (e.g. PFC) 
in alcohol dependence may not be easily inferred from animal models as the severity of 
loss of cognitive control may decrease with descending organism complexity.  
 
In line with this reasoning, negative findings were considered important and worth 
publishing. However, we decided not to further pursue their biological causes as we 
had limited resources (i.e. tissue). Thus, the reach of our conclusions depended on the 
available evidence in favor of the tested hypotheses, which were arguably better for the 
role of ΔFosB in addiction maintenance than the effects of repeated ethanol exposure 
on modulators of synaptic strength. These things said, we acknowledge that our 
findings are correlative and that result interpretation is made difficult by limitations 
related to specificity, postmortem tissue, sample heterogeneity (e.g. incomplete 
abstinence and toxicology data and lack of data on cognitive status) and size. 
 
On the notion that organism complexity stems from progressively more elaborate 
patterns of gene regulation: 1) PDYN appears not to be targeted by AP-1 in vivo (42); 2) 
the RE1 in PDYN is not conserved; 3) Rest appears not to regulate mouse Pdyn (66,67); 
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and 4) rs910080 is located in the RE1 in PDYN (Fig. 1) (27). Together with these 
findings, our results on FOSB proteins and REST lend further support to a role of cis-
regulatory divergence in  transcriptional control of Pdyn (21), and are suggestive of that 
the responsiveness of this gene to ethanol may differ between species and even 
individuals as rs910080 has been associated with alcohol dependence (15). 
 
On the notion that the behavioral flexibility of humans and requirement for cognitive 
control that it imposes is unique to our species: 1) the existence of a DLPFC (e.g. SFG, 
BA9) in non-primate animals is a matter of debate (68); 2) the crucial function of the 
SFG, BA9 is unknown (69); and 3) areas proximal to this area have been implicated in 
loss of ability to abstain from drug seeking in abstinent alcoholics (70). Together with 
these findings, the observation that PDYN gene expression is increased selectively in 
the SFG, BA9 of alcoholic men (14) is suggestive of that similar to the underlying 
molecular mechanisms, the role of this alteration in the psychopathology of alcohol 
dependence (if any) may not be easily inferred from animal studies.  
 
We believe it reasonable to assume that all but two of the alcoholic men included in 
papers I-III were abstinent (only two of them had ethanol in their blood at the time of 
death). Thus, the altered expression of REST target genes (i.e. PDYN and NPTX1) and 
proteins (i.e. dynorphin peptides, NPTX1 and SYP) in the PFC of alcoholic men 
observed in our laboratories may result from abstinence-induced alterations in 
neurotransmission (e.g. increased glutamate transmission) and be involved in 
behavioral phenotypes associated with abstinence (e.g. compulsive drug seeking). 
Testing these hypotheses poses challenges related to species-specificity, but is worth 
the effort as doing so may identify new therapeutic targets for alcohol dependence. 
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6 FUTURE PERSPECTIVES 
 
The role of increased PFC PDYN gene and dynorphin peptide expression in alcohol 
dependence could be investigated in a mouse model of this disorder (71). PDYN gene 
and dynorphin peptide expression in the medial PFC of alcohol dependent, abstinent 
conditional PDYN knockout mice (transgenic mice carrying floxed PDYN) (need to be 
generated) could be correlated with the performance of these mice on the 5-CSRTT (a 
test of cognitive control / behavioral flexibility) (72,73). If increased gene and peptide 
expression in the medial PFC correlated with task performance, canine adenovirus type 
2 carrying Cre recombinase could be injected into the medial PFC to preferentially 
knockout PDYN in neurons this brain region and its afferent projection areas (74). 
Regional specificity could be investigated by injection of adeno-associated virus type 2 
carrying Cre recombinase into the medial PFC (limited retrograde transport). Causality 
could be established by rescue of dynorphin peptide expression via injection of viruses 
of either type carrying floxed PDYN (need to be generated) into this brain region. 
 
If abstinence-induced PDYN gene and dynorphin peptide expression in the medial PFC 
affected cognitive control / behavioral flexibility, the effects of abstinence on REST 
protein localization, expression and localization of splice variants of REST (75), and 
PDYN gene expression could be determined in transduced cells from the medial PFC of 
conditional PDYN knockout mice. If increased PDYN gene expression correlated with 
altered REST protein localization and / or expression and / or localization of splice 
variants of REST, the effects of viruses carrying floxed REST (need to be generated) 
could be investigated. If knockout of PDYN and overexpression of REST protein in the 
medial PFC similarly affected the performance of abstinent conditional PDYN 
knockout mice on the 5-CSRTT, the expression of other REST target genes and 
proteins could be determined in postmortem tissue from the SFG, BA9 of alcoholics to 
further our understanding of the role of this transcriptional control protein in alcohol 
dependence and aiding evaluation of its therapeutic potential for this disorder. 
 
The contribution of κ-opioid receptors to the effects of increased PFC PDYN gene and 
dynorphin peptide expression on cognitive control / behavioral flexibility could be 
investigated using the 5-CSRTT. The effects of κ-opioid receptor agonists and 
antagonists injected into the medial PFC on the performance of naïve mice on this task 
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could be investigated. If the effects of either type of κ-opioid receptor ligand on task 
performance mimicked those observed after abstinence, the therapeutic potential of the 
dynorphin / κ-opioid receptor system for alcohol dependence could be investigated as 
above. κ-opioid receptor occupancy could also be correlated with the performance of 
abstinent mice and alcoholics on the 5-CSRTT and a recently developed incentive 
conflict task (test of reward evaluation) (70), respectively, pending the approval of κ-
opioid radiotracers for use in humans (76-78). This could provide: 1) an in vivo 
measure of dynorphin peptide expression in the PFC by competition with cold ligand; 
and 2) a means to tap into the function of the SFG, BA9 and investigate its role in 
alcohol dependence provided that increasing cognitive load (i.e. task difficulty), which 
results in progressively stronger PFC recruitment (7), would eventually engage it.  
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